StemCell Therapy

(See correction at end of story).

Supporters of Californias multibillion-dollar stem cell program plan to ask for $5 billion more to bring the fruits of research to patients.

Robert Klein, a leader of the 2004 initiative campaign that established the program, said Thursday hes going to be talking with California voters about the proposal. If the public seems receptive, backers will work to get an initiative on the 2016 ballot to extend funding for the California Institute for Regenerative Medicine

Klein outlined the proposal Thursday at UC San Diego Moores Cancer Center, during a symposium on how to speed research to patient care.

Since cancer cells and stem cells share some underlying characteristics, CIRM has funded research into those similarities, including the work of Moores Cancer Center researchers David Cheresh and Catriona Jamieson.

Klein said supporters, including researchers, patients and patient advocates need to educate the public about the benefits of funding stem cell research, and the results to date. A former chairman of CIRM, Klein is no longer formally affiliated with the agency but continues to support its work.

No stem cell treatments funded by CIRM have been approved, but patients have benefited in other ways. CIRM-funded research into cancer stem cells led to a clinical trial of a drug that caused remission of a bone marrow cancer in Sandra Dillon, a patient of Jamiesons. Moreover, California has vaulted into prominence in regenerative medicine, and the field has also provided a new growth engine for the states large biotech industry.

Though CIRM has been praised for advancing quality research, it has been criticized for being slow to fund commercialization by life science companies.

In addition, CIRM has been criticized for a lack of transparency and conflicts of interest in how it awards grants. The agency revamped its policies last year to forbid institutional members of its governing oversight committee from voting on proposals to fund research at any other institution. This was done to prevent the appearance of horse-trading among committee members.

California voters set aside $3 billion in bond money for CIRM in 2004 under Proposition 71. The money is expected to run out around 2017, so Klein and other supporters have been preparing to go back to the public. The amount paid back will be $6 billion, including interest over the life of the bonds, Klein noted. So the $5 billion for CIRM would require a $10 billion bond measure.

Read the original post:
$5 billion initiative proposed for stem cell research

This entry was posted on February 21, 2014 at 10:43 pm and is filed under Cell Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |